| Characteristic |
Seasonal (n=149)a |
Pandemic (n=88)a |
p |
| Age group (years)
|
| 0-10 |
35 (27.3%) |
35 (39.8%) |
*p=0.01 |
| 11-20 |
13 (10.2%) |
11 (12.5%) |
|
| 21-30 |
12 (9.4%) |
13 (14.8%) |
|
| 31-40 |
18 (14.1%) |
4 (4.5%) |
|
| 41-50 |
8 (6.3%) |
11 (12.5%) |
|
| 51-60 |
17 (13.3%) |
8 (9.1%) |
|
| 61-70 |
16 (12.5%) |
6 (6.8%) |
|
| 71-80 |
7 (5.5%) |
0 |
|
| 81-90 |
2 (1.6%) |
0 |
|
| Gender |
| Female |
78 (52.3%) |
41 (46.6%) |
*p=0.235 |
| Male |
71 (47.7%) |
47 (53.4%) |
|
| Viral load |
| (Median [p25-p75]) |
1.86 (0.06-157.58) |
0.05 (0.002-2.44) |
#p<0.001 |
| Vaccine |
| Yes |
33 (28.9%) |
8 (9.5%) |
*p=0.001 |
| No |
81 (71.1%) |
76 (90.5%) |
|
aVaccination status was not informed for all patients
*Statistically significant by Chi-Square Test
#Statistically significant by Mann Whitney U Test
|
